Skip to content

Abstract P92: C11ORF68 is a repressor of inflammatory response under normal and replication stress conditions

Jul 2026 · Cancer Research · Vol 86, pp. P92-P92 · 0 citations

TL;DR

The data suggests that C11ORF68 potentially acts as a repressor of inflammatory response under normal and replication stress conditions, and may also be a mediator of early DDR.

Abstract

Unresolved replication stress (RS) or DNA damage, and inflammation often lead to genomic instability – a feature of many diseases including cancer. Therefore, understanding the molecular foundation of these phenomena is crucial for identifying potential biomarkers or therapeutic targets. Our lab has identified an uncharacterized protein that is symmetrically dimethylated by PRMT5 under hydroxyurea (HU)-induced RS. Therefore, we hypothesize that C11ORF68 is involved in inflammatory and RS response. MCF10A normal breast epithelial cells was used. Depletion of C11ORF68 using siRNA and dicer siRNA (dsiRNA) systems were used to evaluate its function. RNA-seq, qPCR, western blotting and immunofluorescence were used to evaluate the basal and HU-induced inflammatory response. RNA-seq of C11ORF68-depleted cells displayed a basal and RS-induced upregulation of several inflammatory response pathways including interferon alpha and gamma response, and TNF signaling via NF-kB. Selected genes such as CXCL10 and IFIT1 were validated to be upregulated at both basal and RS conditions. This increase in inflammatory gene transcription may be due accumulation of dsDNA in the cytoplasm of C11ORF68-depleted cells. The mechanism of dsDNA leakage into the cytoplasm is currently being investigated. Surprisingly, the observation of cytoplasmic dsDNA was not accompanied with increased DNA damage as there was no basal increase in DNA damage or RS markers such as γH2AX and 53BP1. However, C11ORF68-depleted cells exhibited attenuated activation of DNA damage/RS pathways such as lowered PIKK activation and less repair foci formation after addition of DNA damaging/RS agents. Our data suggests that C11ORF68 potentially acts as a repressor of both basal and RS-induced inflammatory response. C11ORF68 may also be a mediator of early DDR. Mechanisms behind how a nucleolar protein plays role in regulating these phenomena are underway, which may help us understand the involvement of a nucleolar protein in controlling inflammatory and DNA damage/RS responses. Toh Chin Min Clarissa, Hoang Mai Phuong, Hong Liang, Anand Jeyasekharan. C11ORF68 is a repressor of inflammatory response under normal and replication stress conditions [abstract]. In: Proceedings of Frontiers in Cancer Science 2025; 2025 Nov 5-7; Singapore. Philadelphia (PA): AACR; Cancer Res 2026;86(13_Suppl):Abstract nr P92.

View source

Similar papers

Jul 2026

Context-dependent cancer vulnerabilities: CRISPR screening under inflammatory stress.

Genome-wide CRISPR screens have systematically identified genes required for cancer cell survival, yet these studies are typically performed under standardized conditions that do not fully recapitulate the physiological stresses encountered within the tumor microenvironment. In a recent issue of Nature Genetics, Cheruiyot and colleagues perform genome-wide loss-of-function screens under inflammatory conditions induced by interferon-β (IFN-β), interferon-γ (IFN-γ), and tumor necrosis factor (TNF), revealing that distinct cytokines impose different genetic requirements for tumor cell survival. The study shows that inflammatory signaling reshapes genetic dependency landscape in a cytokine-specific manner. Mechanistic analyses identify the glycosylphosphatidylinositol (GPI) transamidase complex and FITM2 as representative examples of genes that become selectively required under inflammatory stress by maintaining membrane protein maturation, endoplasmic reticulum homeostasis, and resistance to oxidative stress. These findings broaden our understanding of how inflammatory cytokines influence tumor cell biology beyond transcriptional regulation and immune recognition. More broadly, the study highlights the value of incorporating physiologically relevant conditions into functional genetic screens, suggesting that conventional dependency maps capture only part of the genetic requirements for tumor survival. Applying similar approaches to other microenvironmental stresses-including hypoxia, metabolic competition, extracellular matrix remodeling, and stromal signaling-may uncover additional therapeutic opportunities for cancer immunotherapy.

Zihan Ning, Guangchuan Wang · 0 citations
Open access Aug 2026

YBX1 regulates RNA polymerase III transcripts to prevent inflammation.

Tolerance of endogenous nucleic acids is crucial for cellular homeostasis and when perturbed can lead to immune dysregulation. RNA-binding proteins (RBPs) bind, modify, and compartmentalize endogenous RNAs to prevent their recognition by the innate immune system. We found that loss of a highly abundant RBP, the cold shock domain containing Y-box binding protein 1 (YBX1), results in the spontaneous induction of an IL6/STAT3 inflammatory response and the upregulation of interferon-stimulated genes. A meta-analysis of other studies reveals that the depletion of YBX1 orthologs and paralogs results in a similar proinflammatory gene signature, suggesting a conserved role of Y-box proteins in maintaining innate immune homeostasis. Among RNAs that interact with YBX1, we tested whether endogenous RNA polymerase III (RNAP III) transcripts stimulate innate immune signaling when YBX1 is depleted. We demonstrate that the inflammatory responses induced by the loss of YBX1 are abrogated by inhibiting RNAP III transcription and RIG-I signaling. Hence, we hypothesize that by regulating RNAP III transcripts, YBX1 prevents their recognition by the innate immune system, uncovering a role of this RBP in maintaining cellular homeostasis and tolerance to endogenous RNAs. The conservation of this phenotype across YBX1 orthologs and paralogs argues that RNA shielding by cold shock domain proteins represents an evolutionarily conserved solution to the problem of endogenous RNA immunogenicity.

Tania Strilets, Sarah Dremel, Mariano A. Garcia-Blanco · 0 citations

Investigating the mechanism of lncRNA SChLAP1 in prostate cancer

A mechanism wherein SChLAP1 modulates AR signaling to promote PCa growth and progression is suggested, suggesting its molecular mechanism and potential to be used as a therapeutic target or biomarker.

Zoe Coutu, Srinivas Somarowthu · 0 citations
Jul 2026

MEX3B as a Potent Regulator of Inflammasome Signaling 2267250

Deletion of MEX3B inhibited caspase-4 and gasdermin D activation, pyroptosis, and secretion of inflammasome-dependent inflammatory cytokines in human cell lines and murine primary macrophages and suggested that MEX3B is a pan-inflammasome regulator targeting inflammatory caspases.

Penghua Wang, Jason G. Cahoon, Duomeng Yang et al. · 0 citations
Review Open access Aug 2026

SKP2 in Cancer: From Molecular Regulation to Therapeutic Vulnerabilities and Translational Perspectives

Emerging evidence has expanded the functional repertoire of SKP2 beyond cell cycle control to encompass metabolism, DNA repair, stemness, tumor microenvironment and immunotherapy response, positioning it as an increasingly attractive target for intervention.

Sheng-An Zheng, Cheng Wang, Xiao-Die Yao et al. · 0 citations